The clinical features, diagnosis and classification of dermatomyositis, Journal of Autoimmunity, vol.48, issue.49, pp.122-129, 2014. ,
DOI : 10.1016/j.jaut.2013.11.005
Httpwwwem-Premiumcomdocelecu- Bordeauxfrdatatraitestmtm-49767 [Internet]. 16 févr, 2011. ,
Inflammatory Muscle Diseases, New England Journal of Medicine, vol.372, issue.18, pp.1734-1781, 2015. ,
DOI : 10.1056/NEJMra1402225
Nouvelles classifications et??physiopathologie des??myopathies inflammatoires, La Revue de M??decine Interne, vol.28, issue.9, pp.603-615, 2007. ,
DOI : 10.1016/j.revmed.2007.03.004
Les nouvelles myopathies inflammatoires, Revue du Rhumatisme, vol.84, issue.5, pp.392-402, 2017. ,
DOI : 10.1016/j.rhum.2017.01.013
Recent advances in dermatomyositis-specific autoantibodies, Current Opinion in Rheumatology, vol.28, issue.6, pp.636-680, 2016. ,
DOI : 10.1097/BOR.0000000000000329
A novel autoantibody to a 155-kd protein is associated with dermatomyositis, Arthritis & Rheumatism, vol.201, issue.11, pp.3682-3691, 2006. ,
DOI : 10.1097/00005792-199111000-00002
Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1?? antibodies in adults with dermatomyositis, Journal of the American Academy of Dermatology, vol.72, issue.3, pp.449-55, 2015. ,
DOI : 10.1016/j.jaad.2014.12.009
Association of distinct clinical subsets with myositis???specific autoantibodies towards anti???155/140???kDa polypeptides, anti???140???kDa polypeptides, and anti???aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single???centre, cross???sectional study, Scandinavian Journal of Rheumatology, vol.47, issue.4, pp.263-270, 2009. ,
DOI : 10.2169/internalmedicine.47.0639
Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.292, issue.7, pp.344-351, 1975. ,
DOI : 10.1056/NEJM197502132920706
Polymyositis and dermatomyositis, The Lancet, vol.362, issue.9388, pp.971-82, 2003. ,
DOI : 10.1016/S0140-6736(03)14368-1
119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, Neuromuscul Disord NMD. mai, vol.14, issue.5, pp.10-12337, 2003. ,
Classifying idiopathic inflammatory myopathies: comparing the performance of six existing criteria, Clin Exp Rheumatol. oct, vol.31, issue.5, pp.767-776, 2013. ,
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy, Clinical Reviews in Allergy & Immunology, vol.42, issue.Suppl, pp.1-19, 2017. ,
DOI : 10.1007/s12016-011-8286-7
Clinical characteristics of patients with anti-TIF1-?? antibodies, Reumatologia/Rheumatology, vol.1, issue.1, pp.14-22, 2016. ,
DOI : 10.5114/reum.2016.58756
Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy, Rheumatology, vol.46, issue.1, pp.25-33, 2007. ,
DOI : 10.1093/rheumatology/kel161
Anti-MDA5 and anti-TIF1-?? antibodies have clinical significance for patients with dermatomyositis, Rheumatology, vol.60, issue.9, pp.1726-1759, 2010. ,
DOI : 10.1002/art.24547
Four dermatomyositis-specific autoantibodies???anti-TIF1??, anti-NXP2, anti-SAE and anti-MDA5???in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort, Autoimmunity Reviews, vol.13, issue.12, pp.1211-1220, 2014. ,
DOI : 10.1016/j.autrev.2014.08.011
Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins, Arthritis & Rheumatism, vol.8, issue.Suppl, pp.513-535, 2012. ,
DOI : 10.1038/nri2413
URL : http://onlinelibrary.wiley.com/doi/10.1002/art.33403/pdf
Factors Predicting Malignancy in Patients with Polymyositis and Dermatomyostis: A Systematic Review and Meta-Analysis, PLoS ONE, vol.115, issue.5, p.94128, 2014. ,
DOI : 10.1371/journal.pone.0094128.s003
Polymyositis/dermatomyositis and Malignancy Risk: A Metaanalysis Study, The Journal of Rheumatology, vol.42, issue.2, pp.282-91, 2015. ,
DOI : 10.3899/jrheum.140566
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay, Rheumatology, vol.65, issue.12, pp.2370-2374, 2010. ,
DOI : 10.1136/ard.2006.052191
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera, Journal of Immunological Methods, vol.433, pp.1-5, 2016. ,
DOI : 10.1016/j.jim.2016.02.017
A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies, Journal of Clinical Laboratory Analysis, vol.384, issue.6, pp.859-66, 2016. ,
DOI : 10.1016/j.jim.2012.07.019
Diagnostic performance of a commercial immunoblot assay for myositis antibody testing, Pathology, vol.48, issue.4, pp.363-369, 2016. ,
DOI : 10.1016/j.pathol.2016.03.012
Dépistage des anticorps dirigés contre les antigènes nucléaires solubles. Rev Fr Lab, juill, issue.384, pp.59-70, 2006. ,
Difficultés d'interprétation des immunodots myosite : exemple d'une réaction croisée entre les anti-centromères A et la protéine TIF1gamma, 2017. ,
Anti-TIF1-gamma antibodies are not associated with other paraneoplastic rheumatic syndromes than dermatomyositis, Arthritis Care & Research, 2017. ,
DOI : 10.1002/acr.23325
Les manifestations pulmonaires du syndrome des antisynth??tases, Revue des Maladies Respiratoires, vol.32, issue.6, pp.618-646, 2015. ,
DOI : 10.1016/j.rmr.2014.07.013
URL : https://doi.org/10.1016/j.rmr.2014.07.013
Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome, Autoimmunity Reviews, vol.11, issue.10, pp.739-784, 2012. ,
DOI : 10.1016/j.autrev.2012.01.006
URL : https://hal.archives-ouvertes.fr/hal-00872923
Phénotypes cliniques et pronostic du syndrome des antisynthétases. Httpwwwem-Premiumcomdocelecu- Bordeauxfrdatarevues02488663v35i7S0248866313006462 [Internet], Disponible sur, 2014. ,
DOI : 10.1016/j.revmed.2013.09.003
Advances in serological diagnostics of inflammatory myopathies, Current Opinion in Neurology, vol.29, issue.5, pp.662-73, 2016. ,
DOI : 10.1097/WCO.0000000000000376
Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy, Arthritis & Rheumatism, vol.247, issue.7, pp.1961-71, 2011. ,
DOI : 10.1007/s004150050585
Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab, Rheumatology, vol.63, issue.6, pp.991-1000, 2016. ,
DOI : 10.1093/rheumatology/ket383
Relevance assessment of requests for antineutrophil cytoplasmic antibodies detection: Retrospective study led in Bordeaux Hospital, France], Rev Med Interne. 6 juill, 2017. ,
Myopathies inflammatoires : diagnostic et classifications. Presse Médicale, juill, vol.38, pp.7-81141, 2009. ,
DOI : 10.1016/j.lpm.2009.01.013
Incidence and prevalence of inflammatory myopathies: a systematic review, Rheumatology, vol.54, issue.1, pp.50-63, 2015. ,
DOI : 10.1016/j.jaad.2005.10.041
The clinical features, diagnosis and classification of dermatomyositis, Journal of Autoimmunity, vol.48, issue.49, pp.122-129, 2014. ,
DOI : 10.1016/j.jaut.2013.11.005
Polymyositis, Neurology, vol.61, issue.3, pp.316-337, 2003. ,
DOI : 10.1212/WNL.61.3.316
Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.292, issue.7, pp.344-351, 1975. ,
DOI : 10.1056/NEJM197502132920706
Classification criteria for polymyositis and dermatomyositis, J Rheumatol. avr, vol.22, issue.4, pp.668-74, 1995. ,
Polymyositis and dermatomyositis, The Lancet, vol.362, issue.9388, pp.971-82, 2003. ,
DOI : 10.1016/S0140-6736(03)14368-1
119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, Neuromuscul Disord NMD. mai, vol.14, issue.5, pp.10-12337, 2003. ,
Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies, Medicine, vol.84, issue.4, pp.231-280, 2005. ,
DOI : 10.1097/01.md.0000173991.74008.b0
Les nouvelles myopathies inflammatoires, Revue du Rhumatisme, vol.84, issue.5, pp.392-402, 2017. ,
DOI : 10.1016/j.rhum.2017.01.013
Polymyositis, Dermatomyositis, and Autoimmune Necrotizing Myopathy: Clinical Features, Rheumatic Disease Clinics of North America, vol.37, issue.2, pp.143-158, 2011. ,
DOI : 10.1016/j.rdc.2011.01.001
An overview of polymyositis and dermatomyositis, Muscle & Nerve, vol.78, issue.5, pp.638-56, 2015. ,
DOI : 10.1097/00005792-199905000-00001
Pulmonary Manifestations of the Idiopathic Inflammatory Myopathies, Clinics in Chest Medicine, vol.31, issue.3, pp.501-513, 2010. ,
DOI : 10.1016/j.ccm.2010.05.008
Pulmonary Complications of Polymyositis and Dermatomyositis, Seminars in Respiratory and Critical Care Medicine, vol.28, issue.4, pp.451-459, 2007. ,
DOI : 10.1055/s-2007-985666
Advances in serological diagnostics of inflammatory myopathies, Current Opinion in Neurology, vol.29, issue.5, pp.662-73, 2016. ,
DOI : 10.1097/WCO.0000000000000376
Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts. Sci Rep. 15 mars 2017, p.188 ,
Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review, Clin Cardiol. nov, vol.35, issue.11, pp.686-91, 2012. ,
Cardiac involvement in polymyositis and dermatomyositis, Autoimmunity Reviews, vol.15, issue.5, pp.462-467 ,
DOI : 10.1016/j.autrev.2016.01.015
Httpwwwem-Premiumcomdocelecu- Bordeauxfrdatatraitestmtm-49767 [Internet]. 16 févr, 2011. ,
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study, The Lancet, vol.357, issue.9250, pp.96-100, 2001. ,
DOI : 10.1016/S0140-6736(00)03540-6
Incidence of Malignant Disease in Biopsy-Proven Inflammatory Myopathy: A Population-Based Cohort Study, Annals of Internal Medicine, vol.134, issue.12, pp.1087-95, 2001. ,
DOI : 10.7326/0003-4819-134-12-200106190-00008
Malignancy and myositis: novel autoantibodies and new insights, Current Opinion in Rheumatology, vol.22, issue.6, pp.627-659, 2010. ,
DOI : 10.1097/BOR.0b013e32833f1075
Classification, Diagnosis, and Management of Idiopathic Inflammatory Myopathies, The Journal of Rheumatology, vol.40, issue.5, pp.550-64, 2013. ,
DOI : 10.3899/jrheum.120682
MRI Findings in Inflammatory Muscle Diseases and Their Noninflammatory Mimics, American Journal of Roentgenology, vol.192, issue.6, pp.1708-1724, 2009. ,
DOI : 10.2214/AJR.08.1764
The idiopathic inflammatory myopathies: spectrum of MR imaging findings., RadioGraphics, vol.15, issue.3, pp.563-74, 1995. ,
DOI : 10.1148/radiographics.15.3.7624563
Inflammatory Muscle Diseases, New England Journal of Medicine, vol.372, issue.18, pp.1734-1781, 2015. ,
DOI : 10.1056/NEJMra1402225
Nouvelles classifications et??physiopathologie des??myopathies inflammatoires, La Revue de M??decine Interne, vol.28, issue.9, pp.603-615, 2007. ,
DOI : 10.1016/j.revmed.2007.03.004
Conventional Cancer Screening versus PET/CT in Dermatomyositis/Polymyositis, The American Journal of Medicine, vol.123, issue.6, pp.558-62, 2010. ,
DOI : 10.1016/j.amjmed.2009.11.012
Recent advances in dermatomyositis-specific autoantibodies, Current Opinion in Rheumatology, vol.28, issue.6, pp.636-680, 2016. ,
DOI : 10.1097/BOR.0000000000000329
Myositis-specific autoantibodies: an important tool to support diagnosis of myositis, Journal of Internal Medicine, vol.73, issue.1, pp.8-23, 2016. ,
DOI : 10.1002/ana.23840
Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis, Arthritis & Rheumatism, vol.448, issue.9, pp.3132-3139, 2007. ,
DOI : 10.1097/00005792-199111000-00002
Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis, Annals of the Rheumatic Diseases, vol.68, issue.10, pp.1621-1626, 2009. ,
DOI : 10.1136/ard.2008.097162
Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort, Annals of the Rheumatic Diseases, vol.72, issue.1, pp.151-154, 2013. ,
DOI : 10.1136/annrheumdis-2012-201736
Clinical and serological characterization of the anti-MJ antibody in childhood myositis, Arthritis Rheum, vol.40, p.139, 1997. ,
Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy, Annals of the Rheumatic Diseases, vol.71, issue.5, pp.710-713, 2012. ,
DOI : 10.1136/annrheumdis-2011-200697
NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis, Arthritis Res Ther, vol.14, issue.2, p.97, 2012. ,
Clinical and Serologic Characterization of an Argentine Pediatric Myositis Cohort: Identification of a Novel Autoantibody (anti-MJ) to a 142-kDa Protein, The Journal of Rheumatology, vol.36, issue.11, pp.2547-51, 2009. ,
DOI : 10.3899/jrheum.090461
Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis, Arthritis & Rheumatism, vol.103, issue.6, pp.1807-1821, 2009. ,
DOI : 10.1056/NEJM197502202920807
Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset, Rheumatology, vol.47, issue.12, pp.2204-2212, 2014. ,
DOI : 10.1093/rheumatology/ken136
Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1??, Arthritis & Rheumatism, vol.146, issue.Suppl, pp.2954-62, 2013. ,
DOI : 10.1001/archdermatol.2009.328
A novel autoantibody to a 155-kd protein is associated with dermatomyositis, Arthritis & Rheumatism, vol.201, issue.11, pp.3682-3691, 2006. ,
DOI : 10.1097/00005792-199111000-00002
Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1?? antibodies in adults with dermatomyositis, Journal of the American Academy of Dermatology, vol.72, issue.3, pp.449-55, 2015. ,
DOI : 10.1016/j.jaad.2014.12.009
Anti-MDA5 and anti-TIF1-?? antibodies have clinical significance for patients with dermatomyositis, Rheumatology, vol.60, issue.9, pp.1726-1759, 2010. ,
DOI : 10.1002/art.24547
Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy, Rheumatology, vol.46, issue.1, pp.25-33, 2007. ,
DOI : 10.1093/rheumatology/kel161
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies, Annals of the Rheumatic Diseases, vol.51, issue.1, pp.17-23, 2014. ,
DOI : 10.1007/978-1-60327-285-8
Anticorps des myopathies autoimmunes : actualit??s des techniques de d??tection et int??r??t clinique, Revue Francophone des Laboratoires, vol.2016, issue.484, 1073740. ,
DOI : 10.1016/S1773-035X(16)30243-X
A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy, Clinical Reviews in Allergy & Immunology, vol.42, issue.Suppl, pp.1-19, 2017. ,
DOI : 10.1007/s12016-011-8286-7
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay, Rheumatology, vol.65, issue.12, pp.2370-2374, 2010. ,
DOI : 10.1136/ard.2006.052191
A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies, Journal of Clinical Laboratory Analysis, vol.384, issue.6, pp.859-66, 2016. ,
DOI : 10.1016/j.jim.2012.07.019
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera, Journal of Immunological Methods, vol.433, pp.1-5, 2016. ,
DOI : 10.1016/j.jim.2016.02.017